Evidence map›Paper›PMID 36506293›Full record

ArticleBrain & spine2022

Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome.

Karl-Michael Schebesch, Julius Höhne, Katharina Rosengarth, Ekaterina Noeva, Nils Ole Schmidt, Martin Proescholdt

Open access · goldAbstract read
In one paragraph

Article in Brain & spine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Digital Twins and Health Care: an Umbrella Review.Journal of medical systems · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Observational
  6. Contemporary surgical strategies for resection of intracranial gliomas.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Karl-Michael SchebeschDepartment of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Julius HöhneDepartment of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Katharina RosengarthDepartment of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Ekaterina NoevaNeuroradiology Branch, Department of Radiology, University Medical Center Regensburg, Regensburg, Germany.
Nils Ole SchmidtDepartment of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Martin ProescholdtDepartment of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
University Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Maximal resection of high-grade glioma (HGG) improves progression-free survival (PFS) and overall survival (OS). Fluorescein sodium (FL) in combination with the YELLOW 560 ​nm filter (Carl Zeiss Meditec, Germany) is a safe and feasible method of visualizing residual tumor tissue during brain tumor resection. Research question: We hypothesized that use of FL positively influenced the volumetric extent of resection (EOR), PFS, and OS in patients undergoing resection of a newly diagnosed HGG. Materials and method: Using a prospective HGG registry, we identified 347 patients (median age 62.4 years; 141 women) with preoperative high-quality magnetic resonance images for volumetric analysis. Resection was performed under white light in n ​= ​151 (43.5%, white-light group) and under FL-guidance in n ​= ​196 (56.5%, FL group). Sex, age, presurgical Karnofsky Performance Index (KPI), O6-Methylguanin-DNA-Methyltransferase-Gene (MGMT) status, and adjuvant treatment modalities were well balanced between the groups. Volumetric analysis was performed by quantifying pre- and postoperative tumor volume based on gadolinium-enhanced T1 sequences in a blinded fashion. Results: In the FL group, postoperative tumor volume was significantly smaller (p ​= ​0.003); accordingly, quantitative EOR was significantly larger (p ​= ​0.003). Significantly more complete resections were achieved in the FL group than in the white-light group (p ​= ​0.003). The FL group showed significantly longer PFS (p ​= ​0.020) and OS (p ​= ​0.015, log rank testing). Multivariate Cox regression modelling showed age, presurgical KPI, MGMT status, and FL-guided resection to be independent prognostic factors for survival. Discussion and conclusion: Compared to white-light resection, FL-guided resection of newly diagnosed HGG significantly improved EOR and prolonged OS.

Indexed as

Extent of resectionFluorescein sodiumFluorescence-guided surgeryHigh-grade gliomaMalignant brain tumorsNeuro-oncologic surgeryNeuro-oncology

Identifiers

PMID36506293
PMCPMC9729812
OpenAlexW4308746470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.